The latest Investing Matters Podcast with Jean Roche, Co-Manager of Schroder UK Mid Cap Investment Trust has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksHemogenyx Regulatory News (HEMO)

Share Price Information for Hemogenyx (HEMO)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1.47
Bid: 1.45
Ask: 1.50
Change: -0.04 (-2.64%)
Spread: 0.05 (3.448%)
Open: 1.45
High: 1.47
Low: 1.448
Prev. Close: 1.515
HEMO Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Holding(s) in Company

16 Nov 2015 12:47

RNS Number : 8539F
Silver Falcon PLC
16 November 2015
 
 
TR-1: NOTIFICATION OF MAJOR INTEREST IN SHARESi

1. Identity of the issuer or the underlying issuerof existing shares to which voting rights areattached: ii

SILVER FALCON PLC

2 Reason for the notification (please tick the appropriate box or boxes):

An acquisition or disposal of voting rights

X

An acquisition or disposal of qualifying financial instruments which may result in the acquisition of shares already issued to which voting rights are attached

An acquisition or disposal of instruments with similar economic effect to qualifying financial instruments

An event changing the breakdown of voting rights

Other (please specify):

3. Full name of person(s) subject to thenotification obligation: iii

Wayne Gibson

4. Full name of shareholder(s)  (if different from 3.):iv

5. Date of the transaction and date onwhich the threshold is crossed orreached: v

16/11/2015

6. Date on which issuer notified:

16/11/2015

7. Threshold(s) that is/are crossed orreached: vi, vii

4%

 

8. Notified details:

A: Voting rights attached to shares viii, ix

Class/type ofshares

if possible usingthe ISIN CODE

Situation previousto the triggeringtransaction

Resulting situation after the triggering transaction

NumberofShares

NumberofVotingRights

Numberof shares

Number of votingrights

% of voting rights x

Direct

Direct xi

Indirect xii

Direct

Indirect

2,144,800

2,144,800

2,600,000

2,600,000

4%

B: Qualifying Financial Instruments

Resulting situation after the triggering transaction

Type of financialinstrument

Expirationdate xiii

Exercise/Conversion Period xiv

Number of votingrights that may beacquired if theinstrument isexercised/ converted.

% of votingrights

C: Financial Instruments with similar economic effect to Qualifying Financial Instruments xv, xvi

Resulting situation after the triggering transaction

Type of financialinstrument

Exercise price

Expiration date xvii

Exercise/Conversion period xviii

Number of voting rights instrument refers to

 

% of voting rights xix, xx

 

 

 

Nominal

Delta

Total (A+B+C)

Number of voting rights

Percentage of voting rights

2,600,000

4%

 

9. Chain of controlled undertakings through which the voting rights and/or thefinancial instruments are effectively held, if applicable: xxi

 

 

Proxy Voting:

10. Name of the proxy holder:

11. Number of voting rights proxy holder will ceaseto hold:

12. Date on which proxy holder will cease to holdvoting rights:

13. Additional information:

14. Contact name:

Wayne Gibson

15. Contact telephone number:

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
HOLGGGACGUPAGPQ
Date   Source Headline
13th Jul 20203:13 pmRNSFurther re Development Agreement
10th Jul 20201:00 pmRNSUS Subsidiary Change of Name
6th Jul 20207:00 amRNSNew Corporate Video and Investor Webinar
1st Jul 202012:58 pmRNSTotal Voting Rights
30th Jun 20204:40 pmRNSSecond Price Monitoring Extn
30th Jun 20204:35 pmRNSPrice Monitoring Extension
30th Jun 20202:06 pmRNSSecond Price Monitoring Extn
30th Jun 20202:00 pmRNSPrice Monitoring Extension
30th Jun 202010:30 amRNSDirector/PDMR Shareholding
26th Jun 20202:06 pmRNSSecond Price Monitoring Extn
26th Jun 20202:00 pmRNSPrice Monitoring Extension
26th Jun 202011:05 amRNSSecond Price Monitoring Extn
26th Jun 202011:00 amRNSPrice Monitoring Extension
26th Jun 20209:05 amRNSSecond Price Monitoring Extn
26th Jun 20209:00 amRNSPrice Monitoring Extension
26th Jun 20207:00 amRNSDevelopment Agmnt - Autoimmune Disease Treatments
24th Jun 20207:00 amRNSHemogenyx Chairman Receives Tang Prize
19th Jun 20202:06 pmRNSSecond Price Monitoring Extn
19th Jun 20202:01 pmRNSPrice Monitoring Extension
15th Jun 20207:00 amRNSCOVID-19 Project Update
9th Jun 202011:05 amRNSSecond Price Monitoring Extn
9th Jun 202011:00 amRNSPrice Monitoring Extension
4th Jun 20203:15 pmRNSResult of AGM and Completion of Placing
2nd Jun 202011:29 amRNSCDX Development Agreement Extension
1st Jun 20202:06 pmRNSSecond Price Monitoring Extn
1st Jun 20202:00 pmRNSPrice Monitoring Extension
29th May 20207:00 amRNSTotal Voting Rights
27th May 20202:32 pmRNSTR-1: NOTIFICATION OF MAJOR INTEREST IN SHARES
18th May 202010:56 amRNSExercise of Warrants
13th May 20209:42 amRNSPosting of Annual Report & Notice of AGM
12th May 20204:41 pmRNSSecond Price Monitoring Extn
12th May 20204:36 pmRNSPrice Monitoring Extension
12th May 20202:22 pmRNSConditional Placing to raise £2,500,000
11th May 20202:06 pmRNSSecond Price Monitoring Extn
11th May 20202:00 pmRNSPrice Monitoring Extension
11th May 20209:05 amRNSSecond Price Monitoring Extn
11th May 20209:00 amRNSPrice Monitoring Extension
7th May 20204:41 pmRNSSecond Price Monitoring Extn
7th May 20204:36 pmRNSPrice Monitoring Extension
7th May 20201:59 pmRNSTR-1: NOTIFICATION OF MAJOR INTEREST IN SHARES
5th May 20204:41 pmRNSSecond Price Monitoring Extn
5th May 20204:36 pmRNSPrice Monitoring Extension
5th May 20202:06 pmRNSSecond Price Monitoring Extn
5th May 20202:00 pmRNSPrice Monitoring Extension
5th May 202011:06 amRNSSecond Price Monitoring Extn
5th May 202011:00 amRNSPrice Monitoring Extension
4th May 20207:00 amRNSTR-1: NOTIFICATION OF MAJOR INTEREST IN SHARES
4th May 20207:00 amRNSTR-1: NOTIFICATION OF MAJOR INTEREST IN SHARES
1st May 20204:41 pmRNSSecond Price Monitoring Extn
1st May 20204:36 pmRNSPrice Monitoring Extension

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.